Endometrial carcinoma: the current role of adjuvant radiation (Q37410937)

20 August 2017

1 reference

title

Endometrial carcinoma: the current role of adjuvant radiation (English)

1 reference

20 August 2017

main subject

endometrial carcinoma

1 reference

A J Fakiris

1 reference

20 August 2017

M E Randall

series ordinal

1 reference

20 August 2017

publication date

1 February 2009

1 reference

Journal of Obstetrics and Gynaecology

20 August 2017

published in

1 reference

20 August 2017

1 reference

20 August 2017

1 reference

20 August 2017

page(s)

81-89

1 reference

High-dose-rate postoperative vaginal cuff irradiation alone for stage IB and IC endometrial cancer

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F01443610802646777

Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802646777

The significance of adnexal involvement in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802646777

The morbidity of treatment for patients with Stage I endometrial cancer: results from a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802646777

Survival after relapse in patients with endometrial cancer: results from a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802646777

Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802646777

Cost-effectiveness analysis of the treatment for intermediate risk endometrial cancer: postoperative brachytherapy vs. observation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802646777

Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802646777

The prognostic significance of vascular invasion by endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802646777

Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802646777

Adjuvant radiotherapy for stage I endometrial cancer: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802646777

Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802646777

High-dose-rate brachytherapy alone post-hysterectomy for endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802646777

Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802646777

Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802646777

Early-stage endometrial cancer: is intravaginal radiation therapy alone sufficient therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802646777

Analysis of FIGO Stage IIIc endometrial cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802646777

Outcome and pattern of failure in pathologic stage I–II papillary serous carcinoma of the endometrium: Implications for adjuvant radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802646777

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802646777

FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802646777

Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802646777

Conservative management of stage I endometrial carcinoma after surgical staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802646777

Effective Treatment of Stage I Uterine Papillary Serous Carcinoma with High Dose-Rate Vaginal Apex Radiation (192Ir) and Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802646777

Stage II endometrial carcinoma: prognostic factors and risk classification in 170 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802646777

Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610802646777

10.1080/01443610802646777

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference